It’s always a good day when a new treatment, especially one for lung cancer, becomes available. It’s even better when the drug trial was stopped early because the results were so clear. Now, Tagrisso is the first adjuvant treatment approved for non-small cell lung cancer.Original Article
You may also like
Insurers Hedge on Trump-Backed Pledge To Improve...
Violence Repeatedly Erupts at Dementia Care Facilities...
Doctors ‘Cringe’ at Possibility of Documenting...
Pregnant Woman’s Roadside Death Triggers Push To...
Tempus to buy cancer test-maker Personalis for $1.5B
Resmed ventilator safety issue linked to 5 serious...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
